Linked Life Data

18622150

Source:http://linkedlifedata.com/resource/pubmed/id/18622150

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-7-14
pubmed:abstractText
Treatment of Nocardia infections continues to be difficult, especially for central nervous system infections or disseminated diseases and when sustained by highly drug-resistant species such as Nocardia farcinica. Linezolid, the first oxazolidinone approved for clinical use, shows an excellent in vitro activity against all species of Nocardia, and achieves good central nervous system and lung concentrations. We describe the case of a patient with pulmonary nocardiosis and intolerance to trimethoprim/sulfamethoxazole successfully treated with linezolid, and review all the published cases of systemic nocardiosis treated with this agent. On the basis of the available evidence, linezolid appears an effective option for the treatment of nocardiosis.
pubmed:language
ita
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1124-9390
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
94-8
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Linezolid therapy for the treatment of nocardial infection: report of a case and review of the literature].
pubmed:affiliation
Dipartimento di Medicina Clinica, Policlinico Umberto I, Universita degli Studi di Roma La Sapienza, Italy.
pubmed:publicationType
Journal Article, Comparative Study, English Abstract, Case Reports